3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Neoplasms
19
Endometrial Neoplasms
14
Ovarian Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Neoplasm Metastasis
7
Squamous Cell Carcinoma of Head and Neck
6
Uterine Cervical Neoplasms
5
Head and Neck Neoplasms
5
Breast Neoplasms
5
Rectal Neoplasms
4
Pancreatic Neoplasms
4
Melanoma
4
Lung Neoplasms
4
Colonic Neoplasms
4
Fallopian Tube Neoplasms
3
Colorectal Neoplasms
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Recurrence
2
Osteosarcoma
2
Multiple Myeloma
2
Carcinoma, Renal Cell
2
Carcinoma, Neuroendocrine
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Turcot syndrome
1
Small Cell Lung Carcinoma
1
Interventions
Radiotherapy
11
Brachytherapy
7
fludarabine
5
Radiation
5
Cyclophosphamide
5
aldesleukin
4
Magnetic Resonance Spectroscopy
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Cisplatin
4
fludarabine phosphate
3
durvalumab
3
Vaccines, Synthetic
3
Radiosurgery
3
Papillomavirus Vaccines
3
Paclitaxel
3
Methods
3
Early Intervention, Educational
3
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
3
tremelimumab
2
entinostat
2
aflibercept
2
Vaccines
2
Trastuzumab
2
Topotecan
2
Therapeutics
2
Platinum
2
Palliative Care
2
Nivolumab
2
Immunoglobulin G
2
Gemcitabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Vaginal Neoplasms
×
dostarlimab
×
Clear all
NCT06023862
2026-05-06
DOVE
Yonsei University
Phase 2
Recruiting
198 enrolled